Free Trial
→ Trump Takes Emergency Action - Plus Elon Musk's New Venture (From Altimetry) (Ad)tc pixel Free PARK Stock Alerts

Park Dental Partners (PARK) Competitors

$18.04 +0.06 (+0.31%)
As of 10:18 AM Eastern
This is a fair market value price provided by Massive. Learn more.
Compare

PARK vs. AUNA, SBC, LFMD, BDSX, and XGN

Should you buy Park Dental Partners stock or one of its competitors? MarketBeat compares Park Dental Partners with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Park Dental Partners include Auna (AUNA), SBC Medical Group (SBC), LifeMD (LFMD), Biodesix (BDSX), and Exagen (XGN). These companies are all part of the "healthcare" industry.

How does Park Dental Partners compare to Auna?

Park Dental Partners (NASDAQ:PARK) and Auna (NYSE:AUNA) are both small-cap healthcare companies, but which is the superior stock? We will compare the two companies based on the strength of their dividends, analyst recommendations, risk, profitability, institutional ownership, media sentiment, valuation and earnings.

Park Dental Partners presently has a consensus price target of $21.75, suggesting a potential upside of 20.60%. Auna has a consensus price target of $6.97, suggesting a potential upside of 41.63%. Given Auna's higher probable upside, analysts clearly believe Auna is more favorable than Park Dental Partners.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Park Dental Partners
1 Sell rating(s)
1 Hold rating(s)
0 Buy rating(s)
2 Strong Buy rating(s)
2.75
Auna
1 Sell rating(s)
2 Hold rating(s)
1 Buy rating(s)
1 Strong Buy rating(s)
2.40

Auna has higher revenue and earnings than Park Dental Partners.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Park Dental Partners$244.49M0.33N/AN/AN/A
Auna$1.23B0.30$27.39M$0.2618.92

In the previous week, Park Dental Partners had 2 more articles in the media than Auna. MarketBeat recorded 2 mentions for Park Dental Partners and 0 mentions for Auna. Park Dental Partners' average media sentiment score of 0.63 beat Auna's score of 0.00 indicating that Park Dental Partners is being referred to more favorably in the media.

Company Overall Sentiment
Park Dental Partners Positive
Auna Neutral

Auna has a net margin of 1.53% compared to Park Dental Partners' net margin of 0.00%. Auna's return on equity of 16.25% beat Park Dental Partners' return on equity.

Company Net Margins Return on Equity Return on Assets
Park Dental PartnersN/A N/A N/A
Auna 1.53%16.25%4.03%

Summary

Auna beats Park Dental Partners on 6 of the 11 factors compared between the two stocks.

How does Park Dental Partners compare to SBC Medical Group?

Park Dental Partners (NASDAQ:PARK) and SBC Medical Group (NASDAQ:SBC) are both small-cap healthcare companies, but which is the superior stock? We will contrast the two companies based on the strength of their dividends, analyst recommendations, institutional ownership, valuation, earnings, profitability, risk and media sentiment.

SBC Medical Group has a net margin of 24.09% compared to Park Dental Partners' net margin of 0.00%. SBC Medical Group's return on equity of 15.90% beat Park Dental Partners' return on equity.

Company Net Margins Return on Equity Return on Assets
Park Dental PartnersN/A N/A N/A
SBC Medical Group 24.09%15.90%11.61%

60.8% of SBC Medical Group shares are held by institutional investors. 10.6% of Park Dental Partners shares are held by insiders. Comparatively, 81.7% of SBC Medical Group shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

SBC Medical Group has lower revenue, but higher earnings than Park Dental Partners.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Park Dental Partners$244.49M0.33N/AN/AN/A
SBC Medical Group$173.61M1.71$50.99M$0.397.43

In the previous week, Park Dental Partners and Park Dental Partners both had 2 articles in the media. SBC Medical Group's average media sentiment score of 1.28 beat Park Dental Partners' score of 0.63 indicating that SBC Medical Group is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Park Dental Partners
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
SBC Medical Group
0 Very Positive mention(s)
1 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Park Dental Partners currently has a consensus price target of $21.75, indicating a potential upside of 20.60%. SBC Medical Group has a consensus price target of $8.50, indicating a potential upside of 193.20%. Given SBC Medical Group's higher probable upside, analysts plainly believe SBC Medical Group is more favorable than Park Dental Partners.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Park Dental Partners
1 Sell rating(s)
1 Hold rating(s)
0 Buy rating(s)
2 Strong Buy rating(s)
2.75
SBC Medical Group
1 Sell rating(s)
0 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.33

Summary

SBC Medical Group beats Park Dental Partners on 9 of the 12 factors compared between the two stocks.

How does Park Dental Partners compare to LifeMD?

Park Dental Partners (NASDAQ:PARK) and LifeMD (NASDAQ:LFMD) are both small-cap healthcare companies, but which is the superior stock? We will compare the two companies based on the strength of their earnings, valuation, dividends, media sentiment, profitability, institutional ownership, analyst recommendations and risk.

LifeMD has a net margin of 2.37% compared to Park Dental Partners' net margin of 0.00%. Park Dental Partners' return on equity of 0.00% beat LifeMD's return on equity.

Company Net Margins Return on Equity Return on Assets
Park Dental PartnersN/A N/A N/A
LifeMD 2.37%-150.88%-22.59%

LifeMD has lower revenue, but higher earnings than Park Dental Partners.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Park Dental Partners$244.49M0.33N/AN/AN/A
LifeMD$194.05M1.21$14.35M$0.0596.78

35.5% of LifeMD shares are held by institutional investors. 10.6% of Park Dental Partners shares are held by insiders. Comparatively, 17.2% of LifeMD shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

In the previous week, Park Dental Partners had 1 more articles in the media than LifeMD. MarketBeat recorded 2 mentions for Park Dental Partners and 1 mentions for LifeMD. LifeMD's average media sentiment score of 1.87 beat Park Dental Partners' score of 0.63 indicating that LifeMD is being referred to more favorably in the news media.

Company Overall Sentiment
Park Dental Partners Positive
LifeMD Very Positive

Park Dental Partners presently has a consensus target price of $21.75, suggesting a potential upside of 20.60%. LifeMD has a consensus target price of $9.14, suggesting a potential upside of 88.94%. Given LifeMD's higher probable upside, analysts clearly believe LifeMD is more favorable than Park Dental Partners.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Park Dental Partners
1 Sell rating(s)
1 Hold rating(s)
0 Buy rating(s)
2 Strong Buy rating(s)
2.75
LifeMD
1 Sell rating(s)
1 Hold rating(s)
8 Buy rating(s)
0 Strong Buy rating(s)
2.70

Summary

LifeMD beats Park Dental Partners on 7 of the 13 factors compared between the two stocks.

How does Park Dental Partners compare to Biodesix?

Park Dental Partners (NASDAQ:PARK) and Biodesix (NASDAQ:BDSX) are both small-cap healthcare companies, but which is the superior stock? We will contrast the two companies based on the strength of their valuation, earnings, media sentiment, analyst recommendations, risk, dividends, institutional ownership and profitability.

21.0% of Biodesix shares are held by institutional investors. 10.6% of Park Dental Partners shares are held by insiders. Comparatively, 23.2% of Biodesix shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

Park Dental Partners has higher revenue and earnings than Biodesix.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Park Dental Partners$244.49M0.33N/AN/AN/A
Biodesix$88.50M1.85-$35.26M-$4.06N/A

In the previous week, Park Dental Partners had 1 more articles in the media than Biodesix. MarketBeat recorded 2 mentions for Park Dental Partners and 1 mentions for Biodesix. Biodesix's average media sentiment score of 1.44 beat Park Dental Partners' score of 0.63 indicating that Biodesix is being referred to more favorably in the news media.

Company Overall Sentiment
Park Dental Partners Positive
Biodesix Positive

Park Dental Partners currently has a consensus target price of $21.75, suggesting a potential upside of 20.60%. Biodesix has a consensus target price of $24.00, suggesting a potential upside of 52.05%. Given Biodesix's higher probable upside, analysts plainly believe Biodesix is more favorable than Park Dental Partners.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Park Dental Partners
1 Sell rating(s)
1 Hold rating(s)
0 Buy rating(s)
2 Strong Buy rating(s)
2.75
Biodesix
1 Sell rating(s)
0 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
2.50

Park Dental Partners has a net margin of 0.00% compared to Biodesix's net margin of -33.26%. Park Dental Partners' return on equity of 0.00% beat Biodesix's return on equity.

Company Net Margins Return on Equity Return on Assets
Park Dental PartnersN/A N/A N/A
Biodesix -33.26%-2,101.40%-35.65%

Summary

Park Dental Partners beats Biodesix on 7 of the 13 factors compared between the two stocks.

How does Park Dental Partners compare to Exagen?

Exagen (NASDAQ:XGN) and Park Dental Partners (NASDAQ:PARK) are both small-cap healthcare companies, but which is the better business? We will contrast the two businesses based on the strength of their risk, valuation, analyst recommendations, dividends, institutional ownership, profitability, media sentiment and earnings.

75.3% of Exagen shares are owned by institutional investors. 10.4% of Exagen shares are owned by company insiders. Comparatively, 10.6% of Park Dental Partners shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Park Dental Partners has a net margin of 0.00% compared to Exagen's net margin of -29.49%. Park Dental Partners' return on equity of 0.00% beat Exagen's return on equity.

Company Net Margins Return on Equity Return on Assets
Exagen-29.49% -94.37% -28.96%
Park Dental Partners N/A N/A N/A

In the previous week, Exagen had 2 more articles in the media than Park Dental Partners. MarketBeat recorded 4 mentions for Exagen and 2 mentions for Park Dental Partners. Park Dental Partners' average media sentiment score of 0.63 beat Exagen's score of 0.61 indicating that Park Dental Partners is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Exagen
0 Very Positive mention(s)
1 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Park Dental Partners
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Exagen presently has a consensus target price of $9.25, indicating a potential upside of 97.27%. Park Dental Partners has a consensus target price of $21.75, indicating a potential upside of 20.60%. Given Exagen's stronger consensus rating and higher possible upside, equities research analysts plainly believe Exagen is more favorable than Park Dental Partners.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Exagen
1 Sell rating(s)
0 Hold rating(s)
8 Buy rating(s)
0 Strong Buy rating(s)
2.78
Park Dental Partners
1 Sell rating(s)
1 Hold rating(s)
0 Buy rating(s)
2 Strong Buy rating(s)
2.75

Park Dental Partners has higher revenue and earnings than Exagen.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Exagen$66.57M1.70-$19.95M-$0.89N/A
Park Dental Partners$244.49M0.33N/AN/AN/A

Summary

Park Dental Partners beats Exagen on 7 of the 13 factors compared between the two stocks.

Get Park Dental Partners News Delivered to You Automatically

Sign up to receive the latest news and ratings for PARK and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding PARK and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

PARK vs. The Competition

Export
MetricPark Dental PartnersServices – Health IndustryServices SectorNASDAQ Exchange
Market Cap$82.26M$1.86B$988.28M$12.31B
Dividend YieldN/AN/A4.70%5.66%
P/E RatioN/A17.0211.3024.76
Price / Sales0.335.9445.12168.32
Price / CashN/A161.8455.6237.92
Price / BookN/A37.7711.666.90
Net IncomeN/A-$33.67M-$12.34M$337.45M
7 Day Performance0.36%5.59%13.79%2.84%
1 Month Performance-0.52%7.35%7.06%4.78%
1 Year PerformanceN/AN/A98.22%33.08%

Park Dental Partners Competitors List

Export
CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
PARK
Park Dental Partners
3.8063 of 5 stars		$18.04
+0.3%		$21.75
+20.6%		N/A$82.26M$244.49MN/A1,208
AUNA
Auna
4.802 of 5 stars		$4.52
+2.5%		$6.97
+54.1%		-21.9%$326.40M$1.23B17.3915,254
SBC
SBC Medical Group
3.7926 of 5 stars		$2.96
-1.7%		$8.50
+187.2%		-35.2%$308.76M$173.61M7.59N/A
LFMD
LifeMD
3.4532 of 5 stars		$5.02
+2.7%		$9.14
+82.1%		-62.3%$236.49M$194.05M100.42230
BDSX
Biodesix
3.6905 of 5 stars		$14.95
-3.3%		$22.00
+47.2%		+162.6%$160.10M$88.50MN/A220

Related Companies and Tools

Related Companies
Top 10 Stock Comparisons

This page (NASDAQ:PARK) was last updated on 6/15/2026 by MarketBeat.com Staff.
From Our Partners
The 1934 playbook
In 1934, a legal government maneuver transferred billions in wealth overnight. Most Americans never saw it com...
American Alternative | Sponsoredtc pixel
Trump's gold order: the announcement they won't put on the front page
On August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...
Reagan Gold Group | Sponsoredtc pixel
Louis Navellier: My #1 AI stock for 2026 (name & ticker inside)
Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top...
InvestorPlace | Sponsoredtc pixel
Trump Takes Emergency Action - Plus Elon Musk's New Venture
Elon Musk has quietly launched a new venture - one that has nothing to do with rockets, EVs, or Neuralink. Tru...
Altimetry | Sponsoredtc pixel
Is SpaceX really worth 1.78 Trillion?
With SpaceX approaching a near-$2 trillion valuation, most investors are focused on the IPO itself - but analy...
InvestPub | Sponsoredtc pixel
Hey, it's Jon Najarian. The SpaceX IPO is right around the corner. But I discovered Elon may have something BIGGER planned. Check this out before June 9th...
After being invited to the SpaceX launch headquarters in Cape Canaveral from one of Elon's top lobbyists… Hall...
Banyan Hill Publishing | Sponsoredtc pixel
CODE RED: AI Meltdown Imminent?
After correctly predicting the 2008 and 2020 stock market meltdowns, I believe this AI company is about to tri...
Paradigm Press | Sponsoredtc pixel
SpaceX is chump change compared to Elon’s $20T ‘iPhone’
Early Apple investors saw peak gains as high as 7,537% after the iPhone launched. Now, multiple insider source...
StocksToTrade | Sponsoredtc pixel